Entero Therapeutics, Inc. financial data

Symbol
ENTO on Nasdaq
Location
777 Yamato Road, Suite 502, Boca Raton, FL
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 329 % -11.4%
Debt-to-equity -1.45K % -1445%
Return On Equity 973 %
Return On Assets -20 % +11.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 4.77M shares
Common Stock, Shares, Outstanding 4.77M shares +62%
Entity Public Float 3.6M USD -46.3%
Common Stock, Value, Issued 477 USD +62.2%
Weighted Average Number of Shares Outstanding, Basic 4.77M shares +108%
Weighted Average Number of Shares Outstanding, Diluted 4.77M shares +108%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 156K USD -95%
General and Administrative Expense 4.4M USD -74.1%
Operating Income (Loss) -4.56M USD +77.3%
Nonoperating Income (Expense) -156K USD -1111%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -675K USD +80.3%
Income Tax Expense (Benefit) 4.26M USD
Net Income (Loss) Attributable to Parent -17.1M USD -58.5%
Earnings Per Share, Basic -5 USD/shares -120%
Earnings Per Share, Diluted -2 USD/shares -110%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.47K USD -99.3%
Accounts Receivable, after Allowance for Credit Loss, Current 20K USD -28.7%
Assets, Current 83.3M USD -1.27%
Property, Plant and Equipment, Net 1.34K USD -95.4%
Operating Lease, Right-of-Use Asset 127K USD -35.1%
Intangible Assets, Net (Excluding Goodwill) 63.4M USD
Goodwill 1.68M USD 0%
Assets 85.1M USD -1.42%
Accounts Payable, Current 3.3M USD +63.8%
Accrued Liabilities, Current 415K USD -77.2%
Liabilities, Current 29.7M USD +92.9%
Deferred Income Tax Liabilities, Net 571K USD
Operating Lease, Liability, Noncurrent 59K USD -59.8%
Liabilities 29.7M USD +91.6%
Retained Earnings (Accumulated Deficit) -205M USD -9.1%
Stockholders' Equity Attributable to Parent -6.3M USD -169%
Liabilities and Equity 85.1M USD -1.42%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -819K USD +78.2%
Net Cash Provided by (Used in) Financing Activities 700K USD -79.3%
Net Cash Provided by (Used in) Investing Activities 88.2K USD
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 4.77M shares +62%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.43K USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 22K USD +144%
Deferred Tax Assets, Valuation Allowance 37.6M USD +12.6%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0 pure -100%
Deferred Tax Assets, Gross 39.6M USD +18.2%
Operating Lease, Liability 141K USD -34.3%
Depreciation 14.6K USD -50.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -15.8M USD -17.8%
Lessee, Operating Lease, Liability, to be Paid 149K USD -36.6%
Property, Plant and Equipment, Gross 87.8K USD 0%
Operating Lease, Liability, Current 136K USD +75.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 60.6K USD -31.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 88.8K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.85K USD -58.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 60.6K USD -31.8%
Deferred Tax Assets, Operating Loss Carryforwards 29.6M USD +28.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 198M USD +0.84%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 34.2K USD +18%
Deferred Tax Assets, Net of Valuation Allowance 1.9M USD +3865%
Share-based Payment Arrangement, Expense 632K USD -39.3%
Interest Expense 79.7K USD +314%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%